Vnitr Lek 2022, 68(5):290-294 | DOI: 10.36290/vnl.2022.062

Diffuse alveolar hemorrhage as a life‑threatening manifestation of newly diagnosed granulomatosis with polyangiitis following COVID-19 infection - a case report

Pavlína Kostelníková1, Martina Skácelová1, Martin Špíšek2, Miroslav Šimíček3, Pavel Horák1
1 III. interní klinika - nefrologická, revmatologická a endokrinologická, FN Olomouc a LF UP Olomouc
2 Interní oddělení, Nemocnice AGEL Valašské Meziříčí, a. s.
3 Plicní ambulance, Nemocnice AGEL Valašské Meziříčí, a. s.

A case report of a patient with newly diagnosed granulomatosis with polyangiitis (GPA) after undergoing COVID-19 (Coronavirus Disease 2019) is discussed. GPA is one of the ANCA-associated vasculitis, which is characterized by the presence of autoantibodies against cytoplasmic enzymes neutrophils (Anti Neutrophil Cytoplasmatic Antibodies). It is a vasculitis that mainly affects small blood vessels, leading to damage to the kidneys, lungs, and upper respiratory tract, including the paranasal sinuses and orbits. This disease can result in an acute life-threatening condition. Such complications include diffuse alveolar hemorrhage (DAH), a condition characterized by blood leakage from the pulmonary vessels into the alveoli, often leading to acute vital signs and even respiratory failure. DAH can have many causes - autoimmune diseases including vasculitides as well as non-immunological causes. Early and adequate comprehensive therapy including immunosuppressive treatment (cyclophosphamide/rituximab and glucocorticoids) can be life-saving.

Keywords: cyclophosphamide, diffuse alveolar hemorrhage, granulomatosis with polyangiitis, plasmapheresis.

Accepted: August 4, 2022; Published: August 22, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kostelníková P, Skácelová M, Špíšek M, Šimíček M, Horák P. Diffuse alveolar hemorrhage as a life‑threatening manifestation of newly diagnosed granulomatosis with polyangiitis following COVID-19 infection - a case report. Vnitr Lek. 2022;68(5):290-294. doi: 10.36290/vnl.2022.062.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Comarmond C, Cacoub P. Granulomatosis with polyangiitis (Wegener): Clinical aspects and treatment. J Autoimmun. 2014;13(8):1121-1125. Dostupné z DOI:. Go to original source... Go to PubMed...
    2. Robson JC, Grayson PC, Ponte C et al. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Granulomatosis With Polyangiitis. Arthritis Rheumatol. 2022;74(3):393-399. Dostupné z DOI: . Go to original source... Go to PubMed...
    3. Bradna P, Maňák J, Soukup T et al. Difuzní alveolární hemoragie - akutní, život ohrožující stav v revmatologii. Vnitř Lék. 2018;64:169-172. Dostupné z DOI: . Go to original source... Go to PubMed...
    4. Krause ML, Cartin‑Ceba R, Specks U et al. Update on diffuse alveolar hemorrhage and pulmonary vasculitis. Immunol Allergy Clin North Am. 2012;32(4):587-600. Dostupné z DOI: . Go to original source... Go to PubMed...
    5. Panikkath D, Gadwala S, Mills B et al. Diffuse alveolar hemorrhage. Southwest respir crit care chron. 2015;3(9):19-27. Dostupné z WWW: . Go to original source...
    6. Löffler C, Mahrhold J, Fogarassy P. Two Immunocompromised Patients With Diffuse Alveolar Hemorrhage as a Complication of Severe Coronavirus Disease 2019. Chest. 2020;158(5):e215-e219. Dostupné z DOI: . Go to original source... Go to PubMed...
    7. Wang E, Lee T, Sharma P et al. The Perfect Storm: Diffuse Alveolar Hemorrhage after SARS‑COV-2 Infection. Chest. 2021;160(4):A1212-A1213. Dostupné z DOI: . Go to original source...
    8. Madanchi N, Stingo FE, Patrick KC et al. Possible Association Between COVID-19 Infection and De Novo Antineutrophil Cytoplasmic Antibody‑Associated Vasculitis. Cureus. 2021;13(12). Dostupné z DOI:. Go to original source... Go to PubMed...
    9. Quadrelli S, Dubinsky D, Solis M et al. Immune diffuse alveolar hemorrhage: Clinical presentation and outcome. Respir Med. 2017;129:59-62. Dostupné z DOI: . Go to original source... Go to PubMed...
    10. De Prost N, Parrot A, Picard C et al. Diffuse alveolar haemorrhage: factors associated with in‑hospital and long‑term mortality. Eur Respir J. 2010;35(6):1303-1311. Dostupné z DOI:. Go to original source... Go to PubMed...
    11. Nasser M, Cottin V. Alveolar Hemorrhage in Vasculitis (Primary and Secondary). Semin Respir Crit Care Med. 2018;39(4):482-493. Dostupné z DOI: . Go to original source... Go to PubMed...
    12. Yates M, Watts RA, Bajema IM et al. EULAR/ERA‑EDTA recommendations for the management of ANCA‑associated vasculitis. Ann Rheum Dis. 2016;75(9):1583-1594. Dostupné z DOI: . Go to original source... Go to PubMed...
    13. Walsh M, Merkel PA, Peh CA et al. Plasma Exchange and Glucocorticoids in Severe ANCA‑Associated Vasculitis. N Engl J Med. 2020;382(7):622-631. Dostupné z DOI: . Go to original source... Go to PubMed...
    14. Čertíková Chábová V. Plazmaferéza a glukokortikoidy u těžké ANCA asociované vaskulitidy. Postgraduální nefrologie. 2020;18(1):21-23. Dostupné z WWW: .
    15. Derebail VK, Falk RJ. ANCA‑Associated Vasculitis - Refining Therapy with Plasma Exchange and Glucocorticoids. N Engl J Med. 2020;382:671-673. Dostupné z DOI: . Go to original source... Go to PubMed...
    16. Chung SA, Langford CA, Maz M et al. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Care Res. 2021;79(8):1088-1105. Dostupné z DOI: . Go to original source... Go to PubMed...
    17. Rawal G. ECMO Rescue Therapy in Diffuse Alveolar Haemorrhage: A Case Report with Review of Literature. J Clin Diagnostic Res. 2016;10(6):10-11. Dostupné z DOI: . Go to original source... Go to PubMed...
    18. Baker MS, Diab KJ, Carlos G et al. Intrapulmonary Recombinant Factor VII as an Effective Treatment for Diffuse Alveolar Hemorrhage: A Case Series. J Bronchology Interv Pulmonol 2016;23(3):255-258. Dostupné z DOI: . Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.